Eplerenone and Morphine drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Eplerenone (eplerenone) and Morphine (morphine sulfate). Common drug interactions include abdominal pain upper among females and hypotension among males.
The phase IV clinical study analyzes what interactions people have when they take Eplerenone and Morphine. It is created by eHealthMe based on reports of 98 people who take the same drugs from the FDA, and is updated regularly.
What is Eplerenone?
Eplerenone has active ingredients of eplerenone. It is often used in high blood pressure. eHealthMe is studying from 9,979 Eplerenone users. Check the latest studies of Eplerenone.
What is Morphine?
Morphine has active ingredients of morphine sulfate. It is often used in pain. eHealthMe is studying from 182,914 Morphine users. Check the latest studies of Morphine.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
98 people who take Eplerenone and Morphine together, and have interactions are studied.

What are the common drug interactions of Eplerenone and Morphine, by gender? *:
female:
- Abdominal pain upper
- Cardiorenal syndrome (kidney failure and heart failure)
- Death
- Disease progression
- Fall
- Nausea (feeling of having an urge to vomit)
- Weight increased
- Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
- Abdominal infection
- Abdominal pain
male:
- Hypotension (abnormally low blood pressure)
- Drug ineffective
- Asthenia (weakness)
- Blood iron decreased
- Decreased appetite
- Depressed mood
- Dyspnoea (difficult or laboured respiration)
- Fear
- Feeding disorder (when children refuse to eat certain food groups)
- Fluid intake reduced
What are the common drug interactions of Eplerenone and Morphine, by age (0-1 to 60+)? *:
0-1:
- Hallucination (an experience involving the perception of something not present)
2-9:
n/a
10-19:
n/a
20-29:
- Abdominal infection
- Abdominal pain upper
- Acidosis (build-up of carbon dioxide in the blood)
- Arterial occlusive disease (slow process through which arteries throughout the body become progressively narrowed and eventually completely blocked)
- Asthenia (weakness)
- Blood cholesterol increased
- Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
- Bronchopleural fistula
- Cardiac failure congestive
- Cardiomegaly (increased size of heart than normal)
30-39:
n/a
40-49:
- Pulmonary arterial hypertension (high blood pressure in the arteries of lungs)
- Cardiac failure
- Fluid overload (too much fluid in the blood)
- Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
- Blood electrolytes decreased
- Blood potassium decreased
- Localised oedema (fluid retention in a particular part of the body)
- Cardiac disorder
- Chronic kidney disease
- Disease complication
50-59:
- Gastric haemorrhage (bleeding stomach)
- Pneumonia
- Chronic kidney disease
- Death
- Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
- Nephrogenic anaemia (anaemia due to kidney disease)
- Axonal neuropathy (dysfunction of axon nerves)
- Blood creatinine increased
- Cardiac failure chronic
- Cardiorenal syndrome (kidney failure and heart failure)
60+:
- Hypotension (abnormally low blood pressure)
- Drug ineffective
- Anxiety
- Asthenia (weakness)
- Blood iron decreased
- Depressed mood
- Dyspnoea (difficult or laboured respiration)
- Fear
- Feeding disorder (when children refuse to eat certain food groups)
- Fluid intake reduced
What are the existing conditions these people have? *
- Ventricular Tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart): 21 people, 21.43%
- Cardiac Failure Congestive: 19 people, 19.39%
- Dyslipidaemia (abnormal amount of lipids): 19 people, 19.39%
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 18 people, 18.37%
- Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 17 people, 17.35%
- Hyperuricaemia (level of uric acid in the blood that is abnormally high): 17 people, 17.35%
- Dyspnea (difficult or laboured breathing): 17 people, 17.35%
- Arrhythmias (irregular heartbeat): 16 people, 16.33%
- Coronary Heart Disease (narrowing or blockage of the coronary arteries): 13 people, 13.27%
- Nausea (feeling of having an urge to vomit): 10 people, 10.20%
* Approximation only. Some reports may have incomplete information.
Do you take Eplerenone and Morphine?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Eplerenone (9,979 reports)
- Morphine (182,914 reports)
Browse all drug interactions of Eplerenone and Morphine:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Eplerenone:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Morphine:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Eplerenone and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Morphine and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Rasmy A, Rahal M, Kisana M, Ahmad S, Salah A, "Morphine induced thrombocytopenia: A case report", Journal of Case Reports and Images in Oncology, 2015 Dec .
- Rasmy A, Rahal M, Kisana M, Ahmad S, Salah A, "Morphine induced thrombocytopenia: A case report", Journal of Case Reports and Images in Oncology, 2015 Dec .
How the study uses the data?
The study uses data from the FDA. It is based on eplerenone and morphine sulfate (the active ingredients of Eplerenone and Morphine, respectively), and Eplerenone and Morphine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Ibrutinib cause Waldenstrom'S Macroglobulinaemia? - 3 seconds ago
- Drug interactions of Pepcid and Nabumetone - 4 seconds ago
- Could Serevent cause Fatigue? - 7 seconds ago
- Could Altace cause Bone Loss? - 7 seconds ago
- Drug interactions of Prochlorperazine Maleate and Bactrim Ds - 9 seconds ago
- Could Ibrance cause Dry Eyes Aggravated? - 11 seconds ago
- Could Ibrance cause Excessive Or Unwanted Hair In Women? - 11 seconds ago
- Ondansetron and Heart Palpitations for Women aged 40-49 - 12 seconds ago
- Ondansetron and Palpitations Aggravated for Women aged 40-49 - 12 seconds ago
- Ondansetron and Heart Pounding for Women aged 40-49 - 13 seconds ago